Jiuliang Yan

Shanghai, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

AK112 (PD-1/VEGF-a bispecific antibody) combined with chemotherapy in locally advanced pancreatic cancer: a case report.

AK112 (PD-1/VEGF-a bispecific antibody) combined with chemotherapy in locally advanced pancreatic cancer: a case report.

Journal: Frontiers in oncology

Published: July 16, 2025

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.

SIGLEC15, negatively correlated with PD-L1 in HCC, could induce CD8+ T cell apoptosis to promote immune evasion.

Journal: Oncoimmunology

Published: July 11, 2024

GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma.

GOLM1 dictates acquired Lenvatinib resistance by a GOLM1-CSN5 positive feedback loop upon EGFR signaling activation in hepatocellular carcinoma.

Journal: Oncogene

Published: February 24, 2024

Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission.

Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission.

Journal: Apoptosis : an international journal on programmed cell death

Published: October 15, 2023

CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.

CRKL dictates anti-PD-1 resistance by mediating tumor-associated neutrophil infiltration in hepatocellular carcinoma.

Journal: Journal of hepatology

Published: June 19, 2023

Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations.

Evolutionary Trajectories of Primary and Metastatic Pancreatic Neuroendocrine Tumors Based on Genomic Variations.

Journal: Genes

Published: July 28, 2022

Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.

Complement C5 is a novel biomarker for liver metastasis of colorectal cancer.

Journal: Journal of gastrointestinal oncology

Published: July 25, 2022

Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips.

Assessment of stromal SCD-induced drug resistance of PDAC using 3D-printed zPDX model chips.

Journal: iScience

Published: April 29, 2022

CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis.

CD44 potentiates hepatocellular carcinoma migration and extrahepatic metastases via the AKT/ERK signaling CXCR4 axis.

Journal: Annals of translational medicine

Published: April 20, 2022

Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro.

Tumor-derived PD1 and PD-L1 could promote hepatocellular carcinoma growth through autophagy induction in vitro.

Journal: Biochemical and biophysical research communications

Published: February 08, 2022

Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma.

Subpopulations of cancer-associated fibroblasts link the prognosis and metabolic features of pancreatic ductal adenocarcinoma.

Journal: Annals of translational medicine

Published: December 29, 2021

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.

PARG inhibition limits HCC progression and potentiates the efficacy of immune checkpoint therapy.

Journal: Journal of hepatology

Published: March 27, 2021

Showing 1-12 of 20

Last Updated: 09/26/2026